Relationship between HbA1c and Continuous Glucose Monitoring in Chinese Population: A Multicenter Study

Objective Since there is a paucity of reference data in the literature to indicate the relationship between HbA1c, and 24 h mean blood glucose (MBG) from continuous glucose monitoring (CGM) in Chinese populations, we described the above relationship in adult Chinese subjects with different glucose tolerance status. Methods Seven-hundred-and-forty-two individuals without history of diabetes were included to the study at 11 hospitals in urban areas across China from 2007–2009 and data of 673 subjects were included into the final analysis. Oral glucose tolerance test (OGTT) classified the participants as nondiabetic subjects, including those with normal glucose regulation (NGR; n = 121) and impaired glucose regulation (IGR; n = 209), or newly diagnosed type 2 diabetes (n = 343). All participants completed testing for HbA1c levels and wore a CGM system for three consecutive days. The 24 h MBG levels were calculated. Spearman correlations and linear regression analyses were applied to quantify the relationship between glucose markers. Results The levels of HbA1c and 24 h MBG significantly increased with presence of glucose intolerance (NGR<IGR<type 2 diabetes; both, P<0.001). Analysis of the total population indicated that HbA1c was strongly correlated with 24 h MBG (r = 0.735). The correlation was also found to be significant for the subgroup of participants with newly diagnosed type 2 diabetes (r = 0.694, P<0.001). Linear regression analysis of the total study population yielded the following equation: 24 h MBG mmol/L = 1.198×HbA1c–0.582 (24 h MBG mg/dL = 21.564×HbA1c–10.476) (R2 = 0.670, P<0.001). The model fit was not improved by application of exponential or quadratic modeling. When HbA1c was 6.5%, the calculated 24 h MBG was 7.2 (6.4–8.1) mmol/L (130 (115–146) mg/dL); and when HbA1c was 7.0%, the 24 h MBG was 7.8 (6.9–8.7) mmol/L (140 (124–157) mg/dL). Conclusions Our study provided the reference data of the relationship between HbA1c and CGM in Chinese subjects.

[1]  Jiang He,et al.  Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.

[2]  A. M. Kyaw,et al.  Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes , 2013, Diabetology & Metabolic Syndrome.

[3]  D. Golicki,et al.  Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials. , 2012, European journal of endocrinology.

[4]  Elizabeth Selvin,et al.  Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based Data , 2011, Annals of Internal Medicine.

[5]  V. Basevi Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[6]  K. Xiang,et al.  Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey , 2010, BMJ : British Medical Journal.

[7]  K. Dou,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[8]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[9]  Weiqing Wang,et al.  Reference Values for Continuous Glucose Monitoring in Chinese Subjects , 2009, Diabetes Care.

[10]  V. Basevi Standards of medical care in diabetes--2007. , 2009, Diabetes care.

[11]  D. Schoenfeld,et al.  Translating the A1C Assay Into Estimated Average Glucose Values , 2008, Diabetes Care.

[12]  L. Thabane,et al.  The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. , 2008, Diabetes research and clinical practice.

[13]  Darrell M. Wilson,et al.  Relationship of A1C to Glucose Concentrations in Children With Type 1 Diabetes , 2008, Diabetes Care.

[14]  A. Haliassos,et al.  Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[15]  John M. Lachin,et al.  Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program , 2007 .

[16]  S. Grundy,et al.  Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus , 2006, Diabetes Care.

[17]  S. Pocock,et al.  Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes , 2006, Diabetes Care.

[18]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[19]  John H Fuller,et al.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.

[20]  F. Nuttall,et al.  Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. , 2004, Diabetes care.

[21]  D. Goldstein,et al.  Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.

[22]  T. Spector,et al.  HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. , 2001, Diabetes.

[23]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[24]  B. Keevil,et al.  Biological Variation of Glycated Hemoglobin: Implications for diabetes screening and monitoring , 1998, Diabetes Care.

[25]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[26]  C. Jackson,et al.  Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia , 1990, Diabetologia.

[27]  Chinese clinical guideline for continuous glucose monitoring (2012). , 2012, Chinese medical journal.

[28]  [Clinical application guide of blood glucose monitoring in China (Edition 2011)]. , 2011, Zhonghua yi xue za zhi.